Multifunctional tumor-targeted nanoparticles for lung cancer

Shinji Kuroda, Tomohisa Yokoyama, Justina O. Tam, Ailing W. Scott, Li Leo Ma, Manish Shanker, Jiankang Jin, Corbin Goerlich, David Willcutts, Jack A. Roth, Konstantin Sokolov, Keith P. Johnston, Rajagopal Ramesh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lung cancer is a major health problem in the United States. Despite the development of molecular-targeting agents such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and advances made in conventional chemoradiotherapy and surgical therapy, the overall five-year survival rate of lung cancer patients remains poor and is less than 15%. Recently, in an attempt to improve diagnosis and therapy, novel technologies such as nanotechnology have emerged for application in medicine. One major goal of nanomedicine is to develop multifunctional nanoparticles that can be applied for diagnosis and imaging of cancer as well as therapy for cancer. As a result, a number of nanoparticle agents of various compositions, sizes, and shapes are being developed. A majority of the nanoparticles, however, are in preclinical studies, and only a few of them have advanced to early clinical testing. Efforts in several laboratories, including our own laboratory, are in developing tumor-targeted multifunctional metal-iron-oxide-based nanoparticles for imaging and therapy of lung cancer. In this article, we will discuss various nanomaterial-based nanoparticles, including our own tumor-targeted multifunctional nanoparticles that are being developed for lung cancer. Readers are encouraged to review additional literature to obtain more information on nanomaterials and their application in nanomedicine and cancer therapy.

Original languageEnglish
Title of host publicationPulmonary Nanomedicine
Subtitle of host publicationDiagnostics, Imaging, and Therapeutics
PublisherPan Stanford Publishing Pte. Ltd.
Pages15-44
Number of pages30
ISBN (Print)9789814316484
DOIs
Publication statusPublished - Jul 31 2012
Externally publishedYes

Fingerprint

Nanoparticles
Tumors
Lung Neoplasms
Nanomedicine
Medical nanotechnology
Neoplasms
Nanostructures
Nanostructured materials
Chemoradiotherapy
Therapeutics
Imaging techniques
Nanotechnology
Medical problems
Iron oxides
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Medicine
Survival Rate
Metals
Technology

ASJC Scopus subject areas

  • Medicine(all)
  • Engineering(all)

Cite this

Kuroda, S., Yokoyama, T., Tam, J. O., Scott, A. W., Leo Ma, L., Shanker, M., ... Ramesh, R. (2012). Multifunctional tumor-targeted nanoparticles for lung cancer. In Pulmonary Nanomedicine: Diagnostics, Imaging, and Therapeutics (pp. 15-44). Pan Stanford Publishing Pte. Ltd.. https://doi.org/10.4032/9789814364140

Multifunctional tumor-targeted nanoparticles for lung cancer. / Kuroda, Shinji; Yokoyama, Tomohisa; Tam, Justina O.; Scott, Ailing W.; Leo Ma, Li; Shanker, Manish; Jin, Jiankang; Goerlich, Corbin; Willcutts, David; Roth, Jack A.; Sokolov, Konstantin; Johnston, Keith P.; Ramesh, Rajagopal.

Pulmonary Nanomedicine: Diagnostics, Imaging, and Therapeutics. Pan Stanford Publishing Pte. Ltd., 2012. p. 15-44.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kuroda, S, Yokoyama, T, Tam, JO, Scott, AW, Leo Ma, L, Shanker, M, Jin, J, Goerlich, C, Willcutts, D, Roth, JA, Sokolov, K, Johnston, KP & Ramesh, R 2012, Multifunctional tumor-targeted nanoparticles for lung cancer. in Pulmonary Nanomedicine: Diagnostics, Imaging, and Therapeutics. Pan Stanford Publishing Pte. Ltd., pp. 15-44. https://doi.org/10.4032/9789814364140
Kuroda S, Yokoyama T, Tam JO, Scott AW, Leo Ma L, Shanker M et al. Multifunctional tumor-targeted nanoparticles for lung cancer. In Pulmonary Nanomedicine: Diagnostics, Imaging, and Therapeutics. Pan Stanford Publishing Pte. Ltd. 2012. p. 15-44 https://doi.org/10.4032/9789814364140
Kuroda, Shinji ; Yokoyama, Tomohisa ; Tam, Justina O. ; Scott, Ailing W. ; Leo Ma, Li ; Shanker, Manish ; Jin, Jiankang ; Goerlich, Corbin ; Willcutts, David ; Roth, Jack A. ; Sokolov, Konstantin ; Johnston, Keith P. ; Ramesh, Rajagopal. / Multifunctional tumor-targeted nanoparticles for lung cancer. Pulmonary Nanomedicine: Diagnostics, Imaging, and Therapeutics. Pan Stanford Publishing Pte. Ltd., 2012. pp. 15-44
@inbook{171fe0d6a88d4a2e982d515f031085fb,
title = "Multifunctional tumor-targeted nanoparticles for lung cancer",
abstract = "Lung cancer is a major health problem in the United States. Despite the development of molecular-targeting agents such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and advances made in conventional chemoradiotherapy and surgical therapy, the overall five-year survival rate of lung cancer patients remains poor and is less than 15{\%}. Recently, in an attempt to improve diagnosis and therapy, novel technologies such as nanotechnology have emerged for application in medicine. One major goal of nanomedicine is to develop multifunctional nanoparticles that can be applied for diagnosis and imaging of cancer as well as therapy for cancer. As a result, a number of nanoparticle agents of various compositions, sizes, and shapes are being developed. A majority of the nanoparticles, however, are in preclinical studies, and only a few of them have advanced to early clinical testing. Efforts in several laboratories, including our own laboratory, are in developing tumor-targeted multifunctional metal-iron-oxide-based nanoparticles for imaging and therapy of lung cancer. In this article, we will discuss various nanomaterial-based nanoparticles, including our own tumor-targeted multifunctional nanoparticles that are being developed for lung cancer. Readers are encouraged to review additional literature to obtain more information on nanomaterials and their application in nanomedicine and cancer therapy.",
author = "Shinji Kuroda and Tomohisa Yokoyama and Tam, {Justina O.} and Scott, {Ailing W.} and {Leo Ma}, Li and Manish Shanker and Jiankang Jin and Corbin Goerlich and David Willcutts and Roth, {Jack A.} and Konstantin Sokolov and Johnston, {Keith P.} and Rajagopal Ramesh",
year = "2012",
month = "7",
day = "31",
doi = "10.4032/9789814364140",
language = "English",
isbn = "9789814316484",
pages = "15--44",
booktitle = "Pulmonary Nanomedicine",
publisher = "Pan Stanford Publishing Pte. Ltd.",

}

TY - CHAP

T1 - Multifunctional tumor-targeted nanoparticles for lung cancer

AU - Kuroda, Shinji

AU - Yokoyama, Tomohisa

AU - Tam, Justina O.

AU - Scott, Ailing W.

AU - Leo Ma, Li

AU - Shanker, Manish

AU - Jin, Jiankang

AU - Goerlich, Corbin

AU - Willcutts, David

AU - Roth, Jack A.

AU - Sokolov, Konstantin

AU - Johnston, Keith P.

AU - Ramesh, Rajagopal

PY - 2012/7/31

Y1 - 2012/7/31

N2 - Lung cancer is a major health problem in the United States. Despite the development of molecular-targeting agents such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and advances made in conventional chemoradiotherapy and surgical therapy, the overall five-year survival rate of lung cancer patients remains poor and is less than 15%. Recently, in an attempt to improve diagnosis and therapy, novel technologies such as nanotechnology have emerged for application in medicine. One major goal of nanomedicine is to develop multifunctional nanoparticles that can be applied for diagnosis and imaging of cancer as well as therapy for cancer. As a result, a number of nanoparticle agents of various compositions, sizes, and shapes are being developed. A majority of the nanoparticles, however, are in preclinical studies, and only a few of them have advanced to early clinical testing. Efforts in several laboratories, including our own laboratory, are in developing tumor-targeted multifunctional metal-iron-oxide-based nanoparticles for imaging and therapy of lung cancer. In this article, we will discuss various nanomaterial-based nanoparticles, including our own tumor-targeted multifunctional nanoparticles that are being developed for lung cancer. Readers are encouraged to review additional literature to obtain more information on nanomaterials and their application in nanomedicine and cancer therapy.

AB - Lung cancer is a major health problem in the United States. Despite the development of molecular-targeting agents such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and advances made in conventional chemoradiotherapy and surgical therapy, the overall five-year survival rate of lung cancer patients remains poor and is less than 15%. Recently, in an attempt to improve diagnosis and therapy, novel technologies such as nanotechnology have emerged for application in medicine. One major goal of nanomedicine is to develop multifunctional nanoparticles that can be applied for diagnosis and imaging of cancer as well as therapy for cancer. As a result, a number of nanoparticle agents of various compositions, sizes, and shapes are being developed. A majority of the nanoparticles, however, are in preclinical studies, and only a few of them have advanced to early clinical testing. Efforts in several laboratories, including our own laboratory, are in developing tumor-targeted multifunctional metal-iron-oxide-based nanoparticles for imaging and therapy of lung cancer. In this article, we will discuss various nanomaterial-based nanoparticles, including our own tumor-targeted multifunctional nanoparticles that are being developed for lung cancer. Readers are encouraged to review additional literature to obtain more information on nanomaterials and their application in nanomedicine and cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=84881682361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881682361&partnerID=8YFLogxK

U2 - 10.4032/9789814364140

DO - 10.4032/9789814364140

M3 - Chapter

SN - 9789814316484

SP - 15

EP - 44

BT - Pulmonary Nanomedicine

PB - Pan Stanford Publishing Pte. Ltd.

ER -